MoneyWorks4Me

Novartis - Quaterly Results

19 May 2022 Evaluate
Revenue reduced marginally to stand at Rs. 983.20 millions during the quarter ended March 2022. The figure stood at Rs. 992.90 millions during the year-ago period.The Net Loss for the quarter ended March 2022 is Rs. -233.70 millions as compared to Net Profit of Rs. 97.00 millions of corresponding quarter ended March 2021The company reported a degrowth in operating Profit to 199.30 millions from 275.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 983.20 992.90 -0.98 3998.70 3813.50 4.86 3998.70 3813.50 4.86
Other Income 143.10 122.70 16.63 331.90 330.90 0.30 331.90 330.90 0.30
PBIDT 199.30 275.40 -27.63 603.00 598.80 0.70 603.00 598.80 0.70
Interest 3.30 27.20 -87.87 48.30 76.80 -37.11 48.30 76.80 -37.11
PBDT -300.40 248.20 -221.03 58.30 522.00 -88.83 58.30 522.00 -88.83
Depreciation 13.10 29.20 -55.14 96.50 121.60 -20.64 96.50 121.60 -20.64
PBT -313.50 219.00 -243.15 -38.20 400.40 -109.54 -38.20 400.40 -109.54
TAX -79.80 122.00 -165.41 -1.00 191.40 -100.52 -1.00 191.40 -100.52
Deferred Tax 21.00 -4.10 -612.20 3.40 -34.80 -109.77 3.40 -34.80 -109.77
PAT -233.70 97.00 -340.93 -37.20 209.00 -117.80 -37.20 209.00 -117.80
Equity 123.40 123.40 0.00 123.40 123.40 0.00 123.40 123.40 0.00
PBIDTM(%) 20.27 27.74 -26.92 15.08 15.70 -3.96 15.08 15.70 -3.96
Peers